CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 901024039
- Phone
- 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- 8-K Event Shareholder vote results
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 8-K/A Event Regulation FD disclosure
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Other events
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- NT 10-K Other NT 10-K
- 8-K Event Agreement ended · Regulation FD disclosure
Page 3 of 24 · 462 filings